The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.128.12.1572

The authors report their experience over an 18-month period with 208 patients who abused amphetamines, barbiturates, and hallucinogens. Although treatment modalities of psychotropic medications and individual and group psychotherapy were offered, almost no patients became engaged in a therapeutic situation. Of 83 patients who were offered continuing care, eight returned for a single visit and one followed through with the recommended treatment.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.